Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04KWO
|
||||
Former ID |
DIB003451
|
||||
Drug Name |
MEDl-551
|
||||
Drug Type |
Antibody
|
||||
Indication | Scleroderma [ICD9: 701.0710.1; ICD10:L94.0-L94.1, M34] | Phase 1 | [531971] | ||
Company |
Astrazeneca; medimmune
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD19 | Target Info | [531971] | ||
NetPath Pathway | IL-7 Signaling Pathway | ||||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.